28269-02-5

Basic information

• Product Name: 1,2-Cyclopentanedicarboxylic acid, 4-oxo-, dimethyl ester, (1R,2S)-rel-
• CAS NO: 28269-02-5
• Molecular Formula: C9H12O5
• Molecular Weight: 200.191
• Mol File: 28269-02-5.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: 1,2-Cyclopentanedicarboxylic acid, 4-oxo-, dimethyl ester, (1R,2S)-rel-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-Cyclopentanedicarboxylic acid, 4-oxo-, dimethyl ester, (1R,2S)-rel-(28269-02-5)
• EPA Substance Registry System: 1,2-Cyclopentanedicarboxylic acid, 4-oxo-, dimethyl ester, (1R,2S)-rel-(28269-02-5)

Safety Data

• Hazardous Substances Data: 28269-02-5(Hazardous Substances Data)

Usage

General Description

The chemical 1,2-Cyclopentanedicarboxylic acid, 4-oxo-, dimethyl ester, (1R,2S)-rel- is a compound with a molecular formula of C9H12O5. It is a dimethyl ester of 1,2-cyclopentanedicarboxylic acid and is also known as (+)-1,2-cyclopentanedicarboxylic acid 4-oxo dimethyl ester. 1,2-Cyclopentanedicarboxylic acid, 4-oxo-, dimethyl ester, (1R,2S)-rel- has potential applications in the fields of medicine, pharmaceuticals, and organic synthesis. It may have properties that make it suitable for use as a building block in the synthesis of various compounds with biological activity. Further research and testing may be required to fully understand the potential uses and implications of this chemical.

Upstream product

• 186581-53-3 diazomethane 
• 92334-74-2 trans(3,4)-3-Hydroxymethyl-4-(1',2'-dihydroxy-ethyl)-cyclopentanol-⁽¹⁾ 
• 4841-84-3 dimethyl cis-1,2,3,6-tetrahydrophthalate 
• 16631-27-9 meso-3,4-bis(methoxycarbonyl)hexanedioic acid 
• 104636-81-9 (1S,2S)-2-((R)-2,2-Di-tert-butyl-[1,3,2]dioxasilolan-4-yl)-4-methylene-cyclopentanecarboxylic acid methyl ester 
• 104636-80-8 (E)-3-((S)-2,2-Di-tert-butyl-[1,3,2]dioxasilolan-4-yl)-acrylic acid methyl ester 
• 17673-68-6 dimethyl trans-cyclohex-4-ene-1,2-dicarboxylate 
• 4373-15-3 1,2,3,4-butanetetracarboxylic acid tetraethyl ester 
• 4534-68-3 1,2,3,4-butanetetracarboxylic acid 
• 67-56-1 methanol 
• 1703-61-3 racemic trans-cyclopentanone-3,4-dicarboxylic acid 
• 16631-27-9 rac-trans-3,4-bis(methoxycarbonyl)hexanedioic acid 
• 37575-81-8 methyl trans-2-(methoxycarbonyl)-4-methylenecyclopentane-1-carboxylate 
• 99837-73-7 4(S),1'(RS),2'(RS)-2,2-dimethyl-4-(2-carbomethoxy-4-methylenecyclopentyl)-1,3-dioxolane 

Downstream Products

• 146144-68-5 trans-(3R,4R)-bis(benzoyloxymethyl)cyclopentanone 
• 138804-29-2 3(S)-trans-3,4-Bis<(benzoyloxy)methyl>cyclopentanone 
• 1445591-99-0 (1R,2R)-2-(methoxycarbonyl)-4-oxocyclopentanecarboxylic acid 
• 115794-30-4 (+)-(1S,2S)-dimethyl-4-oxocyclopentane 1,2-dicarboxylate 
• 35079-19-7 trans-(1R,2R)-1,2-Bis(methoxycarbonyl)-4-oxocyclopentane 
• 115694-82-1 (1S,2S)-2-(methoxycarbonyl)-4-oxocyclopentanecarboxylic acid 
• 1042695-87-3 methyl (1R,2R,4S)-2-[5-hexen-1-yl(methyl)carbamoyl]-4-[[2-(4-isopropyl-1,3-thiazol-2-yl)-7-methoxy-8-methyl-4-quinolinyl]oxy]cyclopentanecarboxylate 
• 1042695-88-4 C₃₁H₃₉N₃O₅S 
• 194918-80-4 2,4-Dioxo-1,3-diaza-spiro[4.4]nonane-7,8-dicarboxylic acid 
• 195209-04-2 ACPT-II 

Relevant articles and documents

PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS

This disclosure provides pharmaceutical compounds to treat medical disorders, such as complement-mediated disorders, including complement Cl -mediated disorders.

Enantioselective synthesis of an advanced intermediate for the synthesis of brefeldin A and analogues

A synthesis of methyl (1R,2R,4S)-2-[(E)-2-iodovinyl]-4-(methoxymethoxy) cyclopentanecarboxylate is described in nine steps from a prochiral anhydride. A desymmetrization reaction followed by an epimerization and a Takai reaction are the key steps of the t

Toward the total synthesis of variecolin

(matrix presented) An annulative approach toward the total synthesis of the sesterterpenoid variecolin (1) is presented. Synthesis of the key hemiketal, containing the core ABC ring skeleton, has been achieved on a model system by an expeditious route uti